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Background: This study provides an example for evaluating learning curve when introducing a new knee
system.
Methods: Thirty-ﬁve investigators across 22 sites prospectively implanted 843 subjects with currently
available products (group A). Seventy-seven investigators across 48 sites prospectively implanted 2330
subjects with the ATTUNE Knee System; in which the ﬁrst 10 subjects for each surgeon were the learning
curve cases (group B, N ¼ 611), and the later subjects were designated as group C (N ¼ 1719). Surgical
time, rates of intraoperative and early postoperative complications, and patient-reported outcome
measures (PROMs) at a minimum of 1 year were compared.
Results: Mean (standard deviation) surgical time was 72.0 (21.6) minutes for group A, 83.0 (24.2) for
group B, and 72.1 (24.1) for group C (P < .001 for group B vs group C; P ¼ .955 for group C vs group A).
Intraoperative, early (<90 day) complication rates, and PROMs were similar for all groups.
Conclusions: The new knee system learning curve was characterized by a slightly longer surgical time
with no negative impact on complications or PROMs.
Level of Evidence: III.
© 2018 The Authors. Published by Elsevier Inc. on behalf of The American Association of Hip and Knee
Surgeons. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
Introduction
Although knee replacement systems, including instruments,
have evolved over the past 5 decades into the contemporary
orthopaedic knee procedures performed today, the surgical tech-
nique has remained essentially unchanged for the past 10 years.
Contemporary innovations in total knee arthroplasty (TKA) are
more subtle and typically include changes in implant and instru-
ment design that through ﬁne-tuning during surgery, surgeonsmay
have the opportunity to optimize outcomes. Studying the learning
curve even with more subtle procedure changes, may be beneﬁcial
to patients, training programs, and to surgeons considering adop-
tion of new systems. Surgeons adopting new technology look to
balance the anticipated patient beneﬁts with the challenges asso-
ciatedwith the surgical learning curve for the technology; however,
the impact of the learning curve on outcomes is not well known.
When comparing the effectiveness of a new primary total knee
system, understanding the variability, magnitude, and duration of
the learning curve may help inform surgeons whether the risk of
getting through the learning curve is worth the end result.
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Learning curves are known to differ between orthopaedic
procedures and therefore cannot be generalized [1]. Presently,
there are no consistent criteria for the reporting of learning curves
[2,3]. The characterization of the learning curve associated with
new technology and/or surgical technique may beneﬁt from
assessments that include the initial skill level of the surgeon, the
learning rate, ﬁnal level of skill achieved, and the duration of the
learning period after which learning has stabilized. Although many
studies recognize that surgeon performance improves with
increasing experience or volume, very few quantify the nature or
duration of the learning curve and impact on patient outcomes. A
traditional approach to the design of trials of new surgical systems
has included intensive training and supervision of surgeons or the
requirement of participating surgeons to perform a ﬁxed number of
procedures before commencing the trial [1,2]. The goal of either
strategy was to help surgeons efﬁciently get through the learning
curve while minimizing risks to patients and to report on the
steady-state skill level surgeons attain.
Although national joint registries are a valuable source of evi-
dence on both established and new implant performance, the
learning curve is inherently embedded in registry reports and
cannot be stratiﬁed by case number of the surgeon between early
and later cases. Therefore, learning curve is overwhelmed by later
cases in the aggregate data. Hence, national joint registries are not
the best approach to study learning curve.
While several editorials [3-5] support studying learning curve,
few published articles [1,6-9] focus on the learning curve, its impact
on outcomes, and even fewer on joint arthroplasty [9]. As well, in
more general publications that report outcomes on subjects
implanted with new technology, seldom describe when and how
study surgeons and operating room staff ascended their individual
learning curve before enrollment of study subjects. Readers are
therefore ill-equipped to “judge whether results are attributable to
the procedure itself or the delivery of the procedure by the sur-
geon” [3]. Simpson summarized that “the learning curve is part and
parcel of that effectivenessdin the real world, the surgeons will
have to ascend that learning curve on real patients, whose
outcomes should count in the overall assessment” [3].
Given the paucity of publications that focus on learning curve,
delivery of care in the operating room, and the potential impact on
subjects, the purpose of this study was to characterize the learning
curve from the perspective of surgical time and subject outcomes as
a part of the introduction of a new primary TKA system. This
multicenter study was designed to commence enrollment with the
ﬁrst product usage of a new system, thereby enabling surgeons to
evaluate the safety and effectiveness of adopting new technology
into their clinical practice.
Material and methods
A total of 90 investigators enrolled subjects into 3 studies that
were part of the same program. Each participating center obtained
institutional review board or ethics committee approval before
enrollment. All selected implanting surgeons were medium- to
high-volume experienced joint surgeons and/or fellowship trained
in primary TKA. Surgeons who enrolled ATTUNE cases received di-
dactic and hands on sawbones/cadaver training before enrolling
their ﬁrst ATTUNE subject. Written informed consent was provided
by all study subjects before their inclusion into their respective
study. Data through November 2017 are presented here for a total of
3173 subjects who were prospectively consented and enrolled. The
studies were nonrandomized, and investigators who enrolled both
groups A and B subjects did so sequentially (group A cases ﬁrst,
followed by group B cases). Most surgeons enrolled only 1 of the 4
possible conﬁgurations (cruciate-retaining ﬁxed bearing [CR FB],
cruciate-retaining rotating platform [CR RP], posterior-stabilized
ﬁxed bearing [PS FB], and posterior-stabilized rotating platform
[PS RP]), consistentwith their standard of care. Participating centers
were instructed to follow their standard of care regarding the
surgical process and with respect to patellar resurfacing.
Currently available TKA cohort (group A)
From October 2011 to March 2015, 35 investigators across 22
sites (from the United States, United Kingdom, Australia, and New
Zealand) consented and enrolled 843 subjects (843 primary TKA)
across all 4 conﬁgurations (211 CR FB, 210 CR RP, 212 PS FB, 210 PS
RP) with a combination of currently available products: 3% NexGen
Complete Knee Solution (Zimmer, Warsaw, IN), 7% Triathlon Knee
System (Stryker, Kalamazoo, MI), or 90% P.F.C. SIGMA Knee System
(DePuy Synthes, Warsaw, IN). Surgeons implanted the knee and
conﬁguration per their standard practice. This cohort was regis-
tered on www.clinicaltrials.gov under registration number:
NCT01497730.
New knee system cohort (ATTUNE, groups B and C combined)
From November 2012 to July 2015, 77 investigators across 48
sites (22 of whom also participated in the group A study) consented
and enrolled 2330 primary TKA subjects with the ATTUNE Knee
System (DePuy Synthes, Warsaw, IN) in 2 clinical studies across
multiple regions (Australia, Austria, Belgium, Canada, Hong Kong,
Germany, Korea, Malaysia, New Zealand, Singapore, Switzerland,
Thailand, United Kingdom, and United States) across all 4 conﬁg-
urations (586 CR FB, 541 CR RP, 636 PS FB, 567 PS RP). The 22 in-
vestigators who had previously enrolled in the group A cohort
remained with their previously selected conﬁgurations apart from
1 investigator who contributed to another conﬁguration. In-
vestigators who had not previously enrolled into the group A cohort
were allowed to implant 1 conﬁguration with the exception of 4
surgeons who implanted a second conﬁguration to help the study
team complete enrollment. The 2 clinical studies which comprise
the combination of groups B and C were registered on www.
clinicaltrials.gov under registration numbers NCT01746524 and
NCT01754363.
Learning curve cohort (group B)
In post hoc summaries of ATTUNE subject data (groups B and C
combined), it was observed that mean surgical time among the ﬁrst
several cases for each surgeon was longer than later cases, but
leveled off with minimal further reduction between 5 and 10 cases.
Based upon these post hoc summaries, it was decided to treat the
ﬁrst 10 ATTUNE subjects for each surgeon as group B. In instances
where it was known that a surgeon had previously implanted AT-
TUNE (before study participation, or other conﬁgurations for study
enrollment), only ATTUNE cases which were known to be among
the surgeon's actual ﬁrst 10 ATTUNE implantations were deemed to
be group B. A total of 611 of the 2330 ATTUNE subjects were
included in group B.
Inclusion/exclusion criteria
Eligibility criteria were similar across all 3 groups. Male and
female patients between 22 and 80 years of age diagnosed with
noninﬂammatory degenerative joint disease were eligible for
enrollment unless excluded for 1 or more of the following
exclusions: psychosocial disorders limiting rehabilitation, previous
partial knee replacement (including unicompartmental, bicom-
partmental, patellofemoral joint replacement, patellectomy),
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previous primary TKA in the affected knee, prior high tibial
osteotomy, those experiencing radicular pain from the spine or a
patient who was pregnant or lactating. In addition, if a patient
required a bilateral TKA, only the ﬁrst knee replacement was to be
enrolled into the study.
Data collection and analysis
Surgical time was the time from ﬁrst incision to the last stitch.
Patient-reported outcome measures (PROMs) included the Knee
injury and Osteoarthritis Outcome Score [10], Oxford Knee Score
[11], and the Patient's Knee Implant Performance Questionnaire
[12,13]. Subjects were seen preoperatively for a clinical assessment
and to collect medical history, PROMs, and radiographs. Subjects
returned to the clinic at less than 1 year (1-303 days) and again at a
minimum of 1 year (304-668) for clinical and radiographic follow-
up and to complete PROMs. The intervals were continuous to
accommodate a broad range of standard of care.
The purpose of this study was to investigate a learning curve
effect on surgical time, intraoperative adverse events, early
postoperative adverse events (<90 days), and PROMs; radiographic
analysis was not examined for a learning curve effect. Surgical time
was compared for group B vs group C and for group C vs group A.
Adverse event comparisons were restricted to local (operative site)
adverse events which were either device related and/or procedure
related; intraoperative and early postoperative adverse events (<90
days) were compared for group B vs group C, and for group C vs
group A cases. Minimum 1-year PROMs were compared for group B
vs group C.
Statistical analysis
Demographic summaries and comparisons of surgical time
and complications were carried out with all consented and
enrolled subjects, whereas comparisons of PROMs were done
with the exclusion of subjects who had major inclusion/exclu-
sion protocol deviations. Surgical times were compared with a
2-sided independent samples t-test, and complication rates
were compared with Fisher's exact test. PROMs were compared
with analysis of covariance models including conﬁguration, age,
Table 1
Minimum 1-year PROMs: group B vs group C with standard deviations (SDs).
Min 1-year PROMS Scale (Unadjusted) mean ± SD Covariate adjusted, P-value
Group B, N ¼ 539 Group C, N ¼ 1456
Knee injury and osteoarthritis outcome score
Activities of daily living 0-100 85.0 ± 16.9 87.1 ± 13.9 .014
Pain 0-100 84.8 ± 16.7 86.0 ± 15.4 .205
Symptoms 0-100 78.9 ± 16.5 80.0 ± 15.0 .120
Function in sport and recreation 0-100 57.5 ± 30.5 58.3 ± 29.6 .778
Quality of life 0-100 70.4 ± 24.4 71.4 ± 22.4 .774
Oxford Knee Score 0-48 40.2 ± 7.4 40.8 ± 6.8 .427
Patient's knee implant performance questionnaire
Overall 0-100 71.0 ± 19.4 73.5 ± 18.5 .019
Conﬁdence 0-10 7.9 ± 2.1 8.2 ± 1.9 .042
Stability 0-10 8.1 ± 2.2 8.4 ± 1.9 .083
Satisfaction 0-10 7.8 ± 2.2 8.0 ± 2.0 .066
Modifying activities 0-10 6.0 ± 3.4 6.5 ± 3.4 .003
All Consented & Enrolled Subjects
N=2330
(N= 611 LC/Group B, N=1719 later cases/Group C)
All Consented & Enrolled Subjects
N=2325
(N= 607 LC/Group B, N=1718 later cases/Group C)
1 Year or Later Follow-Up
N=1995 (88.9%) of 2245
(N= 539 LC/Group B, N=1456 later cases/Group C)
          N=5 Inc/Exc Deviations
• 2 Bilateral subjects (4 TKAs)
•  1 Exc-HTO              
ATTUNE
All Consented & Enrolled Subjects 
N=843 
Group A
Per Protocol Subjects
N=843
1 Year or Later Follow-Up
N=751 (91.7%) of 819
Current Products
N=80 withdrawals
• Revision-3
• Deaths- 2
• Subject withdrew consent- 34
• Investigator decision- 23
• Lost to follow-up-18
N= 24 withdrawals
• Revision- 1
• Deaths- 5
• Subject withdrew consent- 7
• Investigator decision- 0
• Lost to follow-up- 9
• Other reasons - 2
N=0 Inc/Exc Deviationsminus minus
minusminus
Figure 1. Subject ﬂowchart.
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body mass index, gender, preoperative PROMs, and post-
operative time (days of follow-up) as covariates. Summaries of
PROMs in Table 1 show raw-unadjusted mean (standard devia-
tion [SD]), with P-values from respective analysis of covariance
models. Because of the multiple comparisons of PROMs, a
P-value threshold of 0.01 was utilized for determining statistical
signiﬁcance.
Results
Disposition of subjects for group A and the combination of
groups B and C is presented in Figure 1. The dataset of all consented
and enrolled subjects consisted of 843 from group A and 2330 from
the combination of groups B and C. The per-protocol analysis data
set excluded 4 knees in 2 subjects for major protocol deviations
(both knees of staged bilateral knee replacement were enrolled)
and 1 knee in 1 subject for medical history of high tibial osteotomy.
Demographics for all consented and enrolled subjects were similar
(group A vs the combination of groups B and C: mean [SD] age 65.6
[8.2] vs 64.5 [7.9]; female 58.6% vs 60.2%; mean [SD] body mass
index 31.9 [6.4] vs 31.6 [6.1]; diagnosis [osteoarthritis] 98.2% vs
98.8%). Before minimum 1-year follow-up, there were 104 study
withdrawals (24, group A; 80, groups B and C combined) for rea-
sons shown in Figure 1.
Mean (SD) surgical time in minutes was 83.0 (24.2) for group B
and 72.1 (24.1) for group C (P < .001); surgical time for group Awas
72.0 (21.6) (P ¼ .955 vs group C); Figure 2 displays these surgical
time comparisons.
Device- or procedure-related intraoperative operative site
adverse events were experienced by 1.5% (9/611) group B and by
0.8% (13/1719) group C cases (P ¼ .142); the rate for group A was
0.6% (5/843) (P ¼ .803 vs group C). Details for these 27 intra-
operative Adverse Events are presented in Table 2 (all AEs were
reported for distinct subjects). Device- or procedure-related oper-
ative site complications within 90 days postoperative were expe-
rienced by 9.3% (57/611) group B cases and by 8.1% (139/1719)
group C cases (P ¼ .351); the rate for group A was 10.3% (87/843)
(P ¼ .064 vs group C). The types of adverse events for groups A, B,
and C are presented in Table 2 (numbers presented are the tally and
percent of subjects who were reported at least 1 adverse event
within the respective category).
Figure 2. Mean surgical time and standard deviations (whiskers): group B (blue) vs
group C (purple); group C (purple) vs group A (yellow).
Table 2
Type and frequency of intraoperative/postoperative adverse events.
Event, preferred term Current products
(N ¼ 843)
ATTUNE (N ¼ 2330)
Group A (N¼ 843) Group B, learning
curve (N ¼ 611)
Group C, later
cases (N ¼ 1719)
# % # % # %
Intraoperative Joint instability 0 0 4 0.65 4 0.23
Femur fracture 2 0.24 0 0 1 0.06
Complication of device insertion 0 0 1 0.16 1 0.06
Joint dislocation 0 0 0 0 2 0.12
Skeletal injury 0 0 1 0.16 1 0.06
Tendon rupture 1 0.12 1 0.16 0 0
Tibia fracture 1 0.12 0 0 1 0.06
Ligament injury 0 0 0 0 1 0.06
Ligament rupture 0 0 1 0.16 0 0
Tendon injury 1 0.12 0 0 0 0
Peroneal nerve palsy 0 0 0 0 1 0.06
Product quality issue 0 0 1 0.16 0 0
Procedural complication 0 0 0 0 1 0.06
Postoperative (<90 days) Impaired joint movement 52 6.17 27 4.42 74 4.3
Pain 6 0.71 12 1.96 22 1.28
Suspected infection (skin and wound) 9 1.07 6 0.98 10 0.58
Reported infection 8 0.95 1 0.16 12 0.7
Swelling/effusion 1 0.12 8 1.31 11 0.64
Patella crepitation 6 0.71 2 0.33 6 0.35
Hemarthrosis/hematoma 4 0.47 4 0.65 4 0.23
Other 1 0.12 3 0.49 7 0.41
Musculoskeletal/connective tissue related 2 0.24 3 0.49 5 0.29
Instability 0 0 0 0 2 0.12
Deep vein thrombosis 0 0 0 0 1 0.06
Arthropathy 1 0.12 0 0 0 0
Insert dislocation related to manipulation
under anesthesia
0 0 0 0 1 0.06
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Minimum 1-year PROMs summaries for groups B and C are
presented in Table 1. With the exception of the Modifying Activities
Patient's Knee Implant Performance Questionnaire subscore, all P-
values comparing group B vs group C were greater than 0.01 and
not considered to be statistically signiﬁcant.
Discussion
Over the last 50 years, the ﬁeld of hip and knee arthroplasty has
continued to evolve. During this time, the development of inno-
vative implant designs and surgical techniques has had a profound
effect on patients worldwide. Many publications in the orthopaedic
literature on new implant designs and techniques focus on out-
comes and results in expert hands. In many cases, these studies do
not document the learning curve associated with the technique or
implant design. Furthermore, registry data are not well suited to
reporting on learning curves with a speciﬁc implant as they report
aggregate outcomes over time. The purpose of the present study
was to provide an analysis of the learning curve as a part of the
introduction of the ATTUNE Knee System. Overall, we found that
surgeons experience a mild surgical time learning curve that was
completed after 10 cases, with no apparent impact to patient out-
comes or complication rate.
Development of surgical skills has been described in a 3-phase
sequence [14] .The ﬁrst step is gaining cognitive information
related to indications, the decision to perform surgery, and avail-
able alternatives. Part of this phase is understanding how the new
technology would affect patient outcomes as well as aspects of
preoperative, intraoperative, or postoperative care related to the
technology. The second step is task learning with the new tech-
nology. This skill can be developed through hands-on laboratory
programs. In the present study, these 2 phases were addressed
through didactic training followed by hands on sawbone/cadaver
training before surgeons enrolled their ﬁrst ATTUNE subject. The
ﬁnal phase in the development of surgical skills is independence.
During this phase, learning is ongoing, and skills are further reﬁned
and perfected. The primary focus of the present study was during
the phase inwhich surgeons began implanting ATTUNE implants in
subjects.
We divided the surgeon experience into the learning curve
phase (ﬁrst 10 cases, group B) and later cases (group C). This was
based on the observation that there was a modest increase in sur-
gical time for the ﬁrst 5-10 cases that was not demonstrated in later
cases. As a result, the study was designed to compare the early
learning curve period with later cases as well as results from other
currently available products. The learning curve cases (group B)
demonstrated an average surgical time of 83.0 minutes. This was
statistically longer than the surgical time in group C cases (72.1
minutes) and group A cases (72.0 minutes). However, when inter-
preting these data, it is important to note that in this study all
surgeons involved were moderate- to high-volume surgeons.
Therefore, the learning curve period may be longer for lower
volume or less experienced surgeons.
Surgical time alone is not the only variable that must be eval-
uated when considering adopting a new surgical technique or
implant. Potential risks or complications that may be encountered
as well as potential failure rates should be considered. Recent
literature has demonstrated increased complications and risks with
changes in surgical technique. For example, some studies evalu-
ating adoption of the direct anterior exposure in total hip
replacement have demonstrated not only increased surgical time in
early cases but also increased complication rates and higher failure
rates [15-18]. Considering ﬁndings such as those related to learning
curves, we sought to evaluate complications as well as 1-year
outcomes in the present study. There were no signiﬁcant
differences in intraoperative or early postoperative complication
rates between group B and group C cases. Outcome scores for the
learning curve cases (group B) were consistent with later cases
(group C). These data should provide surgeons who are considering
adoption of this implant reassurance about anticipated outcomes in
the learning curve phase.
The strengths of this study include a multicenter design with a
relatively large sample size and deployment across a wide range of
medical systems and countries. This increases the generalizability
of the results. Furthermore, the focus of the study on evaluating the
learning curve phase of implant use is unique. Many studies on new
implant designs do not report on this time period. This type of
information is important for surgeons considering adoption of a
new TKA system as well as the patients who could be part of the
learning curve phase. Therefore, this type of study should be
considered when new TKA systems are released in the future.
The limitations of the present study are as follows. First, this
type of study has not been replicated with other implant designs.
This makes comparison of the results of this study more chal-
lenging. Second, not all surgeons contributed subjects to both
current product (group A) and ATTUNE cohorts (combination of
groups B and C); some surgeons only participated with ATTUNE
implants. Third, we did not evaluate any potential impact of gaps in
enrollment during the learning curve phase but simply focused on
the number of cases completed. It is possible that any long gaps in
enrollment could affect the length of the learning curve period for
some surgeons. Finally, as noted previously, surgeons in this study
were all experienced and/or fellowship-trained, moderate- to high-
volume arthroplasty surgeons. Therefore, these results may not be
generalizable to all surgical teams.
Conclusions
This study provides an example for collecting learning curve
when introducing new products, which others may ﬁnd useful in
future study designs. The results demonstrated a modest learning
curve; after approximately 10 cases, the surgical time was on par
with prior standard of care. Interestingly, the learning curve did not
introduce a negative effect on intraoperative adverse events, early
postoperative adverse events, or PROMs.
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